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A B S T R A C T
Sequenom launched the ﬁrst commercial SNP typing kit for human identiﬁcation, named the iPLEX1
Sample ID Plus Panel. The kit ampliﬁes 47 of the 52 SNPs in the SNPforID panel, amelogenin and two Y-
chromosome SNPs in one multiplex PCR. The SNPs were analyzed by single base extension (SBE) and
Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
In this study, we evaluated the accuracy and sensitivity of the iPLEX1 Sample ID Plus Panel by
comparing the typing results of the iPLEX1 Sample ID Plus Panel with those obtained with our ISO 17025
accredited SNPforID assay. The average call rate for duplicate typing of any one SNPs in the panel was
90.0% when the mass spectra were analyzed automatically with the MassARRAY1 TYPER 4.0 genotyping
software in real time. Two reproducible inconsistencies were observed (error rate: 0.05%) at two
different SNP loci. In addition, four inconsistencies were observed once. The optimal amount of template
DNA in the PCR was 10 ng. There was a relatively high risk of allele and locus drop-outs when 1 ng
template DNA was used. We developed an R script with a stringent set of ‘‘forensic analysis parameters’’
based on the peak height and the signal to noise data exported from the TYPER 4.0 software. With the
forensic analysis parameters, all inconsistencies were eliminated in reactions with 10 ng DNA.
However, the average call rate decreased to 69.9%.
The iPLEX1 Sample ID Plus Panel was tested on 10 degraded samples from forensic case-work. Two
samples could not be typed, presumably because the samples contained PCR and SBE inhibitors. The
average call rate was generally lower for degraded DNA samples and the number of inconsistencies
higher than for pristine DNA. However, none of the inconsistencies were reproduced and the highest
match probability for the degraded samples typed with the panel was 1.7E9 using the stringent
forensic analysis parameters.
Although the relatively low sensitivity of the iPLEX1 Sample ID Plus Panel makes it inappropriate for
typing of trace samples from crime scenes, the panel may be interesting for relationship testing and for
identiﬁcation of e.g. samples in biobanks because of the low reagent costs, the limited hands-on time of
the iPLEX1 assay and the automatic analysis of the mass spectra.
 2013 Elsevier Ireland Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / fs ig1. Introduction
SNPs have attracted a lot of attention within the forensic
community in the last decade. Several SNP panels have been
developed for human identiﬁcation and relationship testing [1–7]
and recently, SNP panels have also been suggested for forensic
phenotyping purposes [8–11]. Assays were developed for these
panels that involved a large multiplex PCR and a large single base* Corresponding author. Tel.: +45 3532 6225; fax: +45 3532 6289.
E-mail address: claus.boersting@forensic.ku.dk (C. Børsting).
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http://dx.doi.org/10.1016/j.fsigen.2013.04.009extension (SBE) multiplex. The SBE products were subsequently
detected by capillary electrophoresis (CE). PCR and CE are widely
used in modern forensic genetic laboratories. Thus, PCR–SBE–CE
assays were easily implemented and also validated for case work in
some laboratories [12–15]. However, analyses of the electropher-
ograms were challenging because the SBE products from the same
locus were detected at different spectral wavelengths and
appeared in different dye windows of the electropherogram, and
because the strengths of the ﬂuorophore emissions from dyes used
in the SBE reaction were unbalanced. Consequently, the peak
height of one allele may be up to six times higher than the peak
height of the other allele in the same locus [12,16]. Furthermore,
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ddNTPs in the SBE reaction were often detected and these products
may be misinterpreted as true alleles [17,18].
The SNPforID consortium (www.snpforid.org) developed a
PCR–SBE–CE assay for human identiﬁcation that made it possible
to amplify 52 autosomal SNPs from diminutive amounts of
genomic DNA [1]. An optimized version of this assay with 49 of
the 52 SNPs was accredited according to the ISO 17025 standard in
2007 [12,16]. The SNPforID panel was used by Applied Biosystems
to develop the GenPlexTM HID system that ampliﬁed 48 of the 52
SNPs and amelogenin. This assay was tested by the forensic
community as a possible alternative to the PCR–SBE–CE assay [19–
21]. However, a commercial forensic kit was never made available.
In 2012, Sequenom launched the iPLEX1 Sample ID Plus Panel
that ampliﬁes 47 of the 52 SNPs in the SNPforID multiplex,
amelogenin and two Y-chromosome markers, XKRY-1 and HFSY-2.
The iPLEX1 protocol involves a large multiplex PCR, a large
multiplex SBE reaction and detection of the SBE products by Matrix
Assisted Laser Desorption/Ionization-Time of Flight Mass Spec-
trometry (MALDI-TOF MS). The protocol requires very little hands-
on time. All reactions (PCR, Shrimp Alkaline Phosphatase (SAP)
treatment, SBE and ion-exchange) are conducted in the same plate
up to the point in the protocol, where the SBE products are
automatically transferred to the SpectroCHIP1 MALDI-TOF MS
target. The mass spectra are analyzed and the SNP calls evaluated
in real-time by the TYPER software on the MassARRAY1 analyzer
system. Furthermore, quality assurance (QA) markers in the PCR
mix, the SAP mix and the SBE mix are used as internal controls for
the different pipetting steps. The QA markers are targets for an SBE
primer and three equally sized peaks from the extension products
are used as an indication of a successful experiment.
In this work, we evaluated the iPLEX1 Sample ID Plus Panel by
comparing the SNP typing results with those obtained with an ISO
17025 accredited PCR–SBE–CE protocol [12].
2. Materials and methods
2.1. Samples, DNA puriﬁcation and DNA quantiﬁcation
A total of 94 samples from individuals in relationship cases
were selected. All samples were previously typed with the
SNPforID multiplex assay [12] as part of the case work investiga-
tion. DNA was puriﬁed from 200 mL of blood using the QIAamp
DNA blood mini kit (Qiagen) as recommended by the manufactur-
er. DNA was eluted in 50 mL of AE buffer.
Seven degraded crime case samples were selected based on STR
typing results from the case work investigation. For three of these
samples, DNA was extracted from two different areas of the sample
material and both preparations were investigated. The crime case
samples were puriﬁed either by a standard phenol/chloroform
extraction protocol [22] or by chelex-100 resin [23]. All DNA
concentrations were determined by real-time PCR using the
QuantiﬁlerTM Human DNA Quantiﬁcation kit (Life technologies-
Applied Biosystems, LT-AB) on an AB 7900 (LT-AB) according to the
manufacturer’s recommendations. The work was approved by the
Danish ethical committee (H-1-2011-081).
2.2. SNP typing
Samples were genotyped using the iPLEX1 Sample ID Plus Panel
(Sequenom). The PCR contained: 0.8 mL H2O, 0.5 mL PCR buffer
(20 mM MgCl2), 0.4 mL 25 mM MgCl2, 0.1 mL 25 mM dNTP mix,
1 mL forward/reverse primer mix (500 nM each), 0.5 mL QC
competitor, 0.5 mL QA spike, 0.2 mL PCR enzyme and 1 mL sample
DNA. The PCR was performed in an GeneAmp1 PCR system 9700
thermal cycler (LT-AB) with the following conditions: denaturationat 94 8C for 2 min followed by 45 cycles of 94 8C for 20 s, 62 8C for
30 s, 72 8C for 1 min, followed by 72 8C for 3 min. The PCR products
were treated with a cocktail of 1.53 mL H2O, 0.17 mL 10 SAP
Buffer and 0.3 mL Shrimp Alkaline Phosphatase (1.7 U/mL) (SAP)
(Sequenom) in a GeneAmp1 PCR system 9700 thermal cycler (LT-
AB) at 37 8C for 40 min followed by 85 8C for 5 min. The SBE
reaction contained 7 mL SAP treated PCR products and 2 mL iPLEX1
pro mix (Sequenom). The iPLEX1 pro mix contained 0.2 mL 10
iPLEX1 pro buffer plus, 0.2 mL iPLEX1 pro Termination mix,
0.94 mL primer mix (0.74–1.46 mM, Sequenom), 0.041 mL iPLEX1-
enzyme, 0.5 mL EXT QA spike, and 0.119 mL H2O. The SBE reaction
was performed on a GeneAmp1 PCR system 9700 thermal cycler
(LT-AB) with the following conditions: denaturation at 95 8C for
30 s followed by 40 cycles of 95 8C for 5 s, 52 8C for 5 s, 80 8C for 5 s,
52 8C for 5 s, 80 8C for 5 s, 52 8C for 5 s, 80 8C for 5 s, 52 8C for 5 s,
80 8C for 5 s, 52 8C for 5 s, 80 8C for 5 s, followed by 72 8C for 3 min.
A total of 41 mL of molecular grade water and ion exchange resin
(Sequenom) was added to each sample.
Samples were rotated for approximately 5 min on a tube rotator
(VWR) and centrifuged at 3600 rpm for 5 min. All SBE products
were spotted twice on the SpectroCHIP array (Sequenom) using the
RS1000 nanospotter (Sequenom). Results were visualized on the
MassARRAY1 analyzer 4 system (Sequenom) using the autorun
settings. All samples were typed in duplicate. There were no
signiﬁcant difference between the call rates from the two spots
(supplementary table S1, p = 0.11). All analyses were performed
with the results from the ﬁrst spot from each sample.
2.3. Data analysis
The MassArray TYPER 4.0 genotyping software analyzed the
results in real time using a Gaussian mixture model for cluster
analyses. The credibility of the SNP calls were evaluated as a
posterior probability using a non-disclosed formula in the
MassArray TYPER 4.0 software and the SNP calls were divided
into 3 groups; Conservative, Moderate and Aggressive genotype
calls. A forth group named Low Probability SNP calls contained
genotypes with skewed allele balances or low signal to noise ratios.
The Low Probability SNP calls were not accepted as genuine SNP
genotypes by the TYPER 4.0 genotyping software. If no extended
SBE primers were detected at a locus, the genotype call was
categorized as No alleles.
For further analyses of the data, the Plate Data File with signal to
noise ratios (SNR) and peak heights were exported from TYPER 4.0
and imported into the statistical computing software R v.2.11.0
(http://CRAN.R-project.org/doc/FAQ/R-FAQ.html; ISBN 3-900051-
08-9). The allele balance (AB) was calculated in R as AB = (height of
allele 1  height of allele 2)/(height of allele 1 + height of allele 2).
A set of ‘‘forensic analysis parameters’’ for analysis were deﬁned;
peak height > 1.5, SNR > 5 and jABj > 0.8 for homozygotes and
jABj < 0.2 for heterozygotes. jABj > 0.8 translates to a genotype call
where the peak height of one allele was at least 9 times higher than
the peak height of the other allele. jABj < 0.2 translates to a
heterozygous genotype call where the peak height of one allele was
maximally 1.5 times the peak height of the other allele. The signal
from the G allele of the SNP rs2111980 was weak (supplementary
Fig. S1). For rs2111980, jABj > 0.9 for homozygotes and
0.3 < AB < 0.7 for heterozygotes. The heterozygous genotype calls
of rs2111980 were manually changed and marked as a user deﬁned
call.
3. Results
The iPLEX1 Sample ID Plus Panel was evaluated by duplicate
typing of puriﬁed DNA from 94 individuals. Two experiments were
performed independently of each other on two different days. Two
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the SAP quality assurance marker in one sample was not detected
and the spotting of another sample failed completely. The two
samples were subsequently excluded from the analyses described
below.
The results were analyzed using the MassArray TYPER 4.0
genotyping software in real-time mode. The average call rate for
duplicate typing of any one SNP in the iPLEX1 Sample ID Plus Panel
was 90.0% (for details on each SNP, see supplementary Table S2),
6.5% were typed successfully once and 3.5% were not typed in
either experiment. Only one discrepancy between the ﬁrst and
second experiment was observed (in rs873196). The genotyping
successes of three SNPs were poor. The SNP rs735155 was only
typed in duplicate in one individual (see below) and the call rates
for duplicate typing of rs1029047 and rs1031825 were only 57%
and 54%, respectively. Without these three SNPs, the average call
rate for duplicate typing of any SNP in the panel would be 93.5%.
The signal from the rs2111980 G allele was weaker than the
signal from the A allele (supplementary Fig. S1) which resulted in a
peak height ratio of approximately 3:1 (A:G) for heterozygous
individuals. The TYPER 4.0 software did not automatically accept
heterozygous allele calls for rs2111980 as genuine and thus, the
heterozygous genotype calls were manually changed and marked
as user deﬁned allele calls (Fig. 1).
The consensus SNP proﬁles generated from duplicate typing
with the iPLEX1 Sample ID Plus Panel were compared to those
obtained with an ISO 17025 accredited investigation of the same
SNPs [12]. Two reproduced inconsistencies were detected; one in
the rs717302 locus and one in the rs735155 locus (observed in two
different individuals).Fig. 1. Distribution of genotype calls. (A) TYPER 4.0 software analysis parameters. (B) F
forensic analysis parameters (homozygote allele balance (AB) 0.8 and heterozygote ABFurthermore, one inconsistency was observed in the
rs873196 locus in one of the two experiments, and three
inconsistencies were observed (two in rs717302 and one in
rs1031825) in loci where the second experiment did not
generate any result. Six of the eight inconsistencies were allele
drop-outs and two were allele drop-ins (both in rs735155).
Three of the eight inconsistencies were detected in the three
poorly performing SNPs, rs735155, rs1029047 and rs1031825,
and four of the remaining ﬁve inconsistencies were found in
rs717302.
The typing results of the sex markers AMEL, XKRY-1 and HFSY-2
matched the known gender of all 94 individuals.
3.1. Forensic analysis parameters
The distribution of the ﬁve different genotype categories
(Conservative, Moderate, Aggressive, Low-probability and No-
alleles) reported by the TYPER 4.0 software is shown in Fig. 1A. The
peak height, signal to noise and allele balance are clearly important
parameters for the evaluation of the typing result.
The genotypes of the eight inconsistencies were deﬁned as
Conservative (2), Moderate (5) and Aggressive (1). We decided to
develop a stringent set of ‘‘forensic analysis parameters’’ based on
the peak height and the signal to noise data exported from the
TYPER 4.0 software. This way of analyzing the data eliminated all
inconsistencies. The R script is available in supplementary Table
S3. The minimum requirements for peak height, signal to noise and
allele balance may be altered by the user. Also, individual
requirements for a given locus may be deﬁned, e.g. for the
rs2111980 locus, where the allele balance was approximately 3:1,orensic analysis parameters. Red lines represent the ratio restrictions used for the
 0.2).
Table 1
The effect of different analysis parameters on the call rate and the distribution of genotype calls.
Call TYPER 4.0 calls SNR > 5 Peak height > 1.5 SNR > 5 and
peak height > 1.5
Allele balance Forensic analysis
parameters
Conservative 13,155 75 647 663 120 754 (5.7%)
Moderate 2519 87 271 280 984 1215 (48.2%)
Aggressive 519 30 77 82 493 517 (99.6%)
Low probability 932 490 534 549 678 924 (99.1%)
No-alleles 235 235 235 235 235 235 (100%)
User deﬁned 171 0 7 7 0 7 (4.1%)
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(see Section 2).
The distribution of genotype categories after analysis with the
forensic analysis parameters is shown in Fig. 1B. The effect of the
individual parameters is shown in Table 1.
The numbers of acceptable Moderate and Aggressive calls were
reduced considerably mainly by the more stringent requirements
on the allele balance. Some Conservative calls were also eliminat-
ed, mostly by the increased peak height requirement. The average
call rate for duplicate typing of any one SNP in the iPLEX1 Sample
ID Plus Panel with the forensic analysis parameters was 69.9% (for
details on each SNP, see supplementary Table S2). The call rates of
ﬁve SNPs (rs1029047, rs1490413, rs717302, rs733164 and
rs737681) were reduced by more than half when the forensic
analysis parameters were used.
3.2. Sensitivity of the iPLEX1 Sample ID Plus Panel
The sensitivity of the iPLEX1 Sample ID Plus Panel was tested
by typing ﬁve samples in seven different dilutions (40–0.625 ng).
The average call rates of the analyzed results using either the
TYPER 4.0 software or the forensic analysis parameters are shown
in Fig. 2. As expected, the average call rates were lower when the
forensic analysis parameters were used. The optimal amount of
DNA in the PCR seemed to be 10 ng. Fourteen inconsistencies
were observed between SNP proﬁles analyzed with the TYPER 4.0
software and the SNP proﬁles generated with the ISO 17025
accredited investigation [12]. All the inconsistencies were
detected in the experiments where 1.25 ng or 0.625 ng DNAFig. 2. Sensitivity study. Call rates with the TYPER 4.0 software (A) and the forensicwas used in the PCR. Twelve of the inconsistencies were allele
drop-outs and two were allele drop-ins. When the forensic
analysis parameters were used, four inconsistencies remained. All
of them were allele drop-outs.
3.3. Typing of degraded DNA
Seven crime case samples were selected for duplicate typing
with the iPLEX1 Sample ID Plus Panel. For three of these samples,
DNA was extracted from two different areas of the sample material
and both preparations were investigated.
The samples were previously typed with the AmpF‘STR1 SEﬁler
PlusTM PCR ampliﬁcation kit using the validated protocol for crime
case samples [24] and partial STR proﬁles were obtained in all
samples except for sample 8 (Table 2) [25]. Complete SNP proﬁles
were obtained with the SNPforID PCR–SBE–CE assay [25].
The call rates for the duplicate typing using either the TYPER 4.0
software or the forensic analysis parameters are shown in Table 2
and the SNP proﬁles from the individual experiments are shown in
supplementary Tables S4 and S5. As expected, the call rates were
generally lower than those obtained with pristine DNA samples.
Nevertheless, the match probabilities for the consensus proﬁles
based on the forensic analysis parameters ranged from 1.7E09
(sample 1) to 1.2E16 (sample 6).
No reproducible results were obtained for sample 2 and 8
even though the samples were investigated four times. Partial
SNP proﬁles were obtained once but the result could not be
repeated. Interestingly, the signals from the QA markers were
very weak in the experiments where no signals were detected, analysis parameters (B) using seven different dilutions of DNA (40–0.625 ng).
Table 2
Call rates of SNP and STR typing of degraded DNA.
Sample Sample material Call rate
AmpF‘STR1 SEﬁler PlusTM TYPER 4.0 Forensic analysis parameters
1 FFPEy tissuez 33% 81% 53%
2 FFPEy tissue^ 66% 0 0
3 Nailz 66% 60% 45%
4 Nail§ 25% 77% 60%
5 Cigaret bud 92% 64% 53%
6 Cigaret bud 92% 89% 81%
7 Blood 50% 74% 60%
8 Muscle§,^ 100% 0 0
9 Bloodz 75% 53% 45%
10 Blood 66% 79% 62%
^ Partial SNP proﬁles were obtained in one out of four experiments.
§ The internal PCR control in the Quantiﬁler1 kit was partially inhibited.
y FFPE = formalin ﬁxed parafﬁn embeded.
z Used in a GenPlexTM HID system interlaboratory exercise [20].
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internal PCR control was inhibited in the real-time quantiﬁca-
tion reaction of sample 8 (data not shown) which conﬁrmed the
presence of PCR inhibitors in the DNA preparation, but no
inhibition was observed for sample 2.
Twelve inconsistencies were observed between the SNP
proﬁles analyzed with the TYPER 4.0 software and the SNP
proﬁles generated with the SNPforID PCR–SBE–CE assay [25].
They were detected in 11 different loci and none of them were
reproduced (supplementary Table S4). Seven of the inconsis-
tencies were observed in loci where the second experiment did
not generate a result. All the inconsistencies were allele drop-
outs. Four inconsistencies remained after the iPLEX1 Sample ID
Plus Panel results were analyzed with the forensic analysis
parameters.
4. Discussion
Although the forensic community has invested a lot of research in
the possible use of SNPs for forensic genetic testing, few laboratories
have implemented or validated SNP typing assays [12–15]. The
widely used PCR–SBE–CE assay has proved to be an excellent
research tool. However, as a routine investigation in a forensic
genetic context, the assay is deselected in favor of the constantly
improving commercial STR kits. There are presently no commercial
PCR–SBE–CE kits for forensic genetic testing. Thus, all maintenance
of the assay including tests of new primer stocks, test and validation
of each new primer mix etc. must be performed in-house. Also, there
is no commercial software that can analyze the unbalanced signals
with different ﬂuorophores efﬁciently, or employ the locus speciﬁc
guidelines that are important for standardization of the analyses
[12] and for detection of mixtures [15].
These inconveniences were overcome with the iPLEX1 Sample
ID Plus Panel. All reactions in the iPLEX1 protocol were performed
in the same plate with little hands-on time, the peaks from the two
alleles in each locus were of almost equal size and the analyses
were performed automatically by the TYPER 4.0 software. The
evaluation of the iPLEX1 Sample ID Plus Panel described in this
work showed that both pristine and degraded crime case samples
may be typed accurately with the assay. Clearly, the call rates of
some of the SNPs were not impressive. In particular, the
rs1029047, rs1031825, rs1490413, rs717302, rs733164,
rs735155 and rs737681 loci should either be removed from the
panel or the individual SNP assays should be redesigned and
optimized. The QA markers were a valuable addition to the assay
and may work as an internal control for SBE (and PCR) inhibition.
The QA markers required manual inspection, which seemedawkward when they might as well be analyzed automatically
with the TYPER 4.0 software.
The inconsistencies observed between the iPLEX1 Sample ID
Plus Panel proﬁles and the SNP proﬁles generated with the
SNPforID PCR–SBE–CE assay were a matter of grave concern. We
developed a set of forensic analysis parameters and re-analyzed
the data in the statistical software R using an in-house developed
script (supplementary Table S3). The forensic analysis parameters
were more stringent than the ones used by the TYPER 4.0 software
and the majority of the inconsistencies were eliminated. However,
the forensic analysis parameters reduced the average call rate
considerably (from 90% to 69.9%). For some loci, the call rate was
more than halved and the individual SNP assays for these loci
should be optimized (see above).
High sensitivity is pivotal for crime case investigations
because the trace samples collected from crime scenes often
contain very little DNA (<1 ng). The iPLEX1 Sample ID Plus
Panel required 10 ng for optimal performance. This is 50–100
times more than the amount of DNA typically used in the PCR of
forensic genetic STR kits. Furthermore, allele drop-outs seemed
to occur frequently when the PCR was set up with 1 ng or less.
Therefore, the iPLEX1 Sample ID Plus Panel is not attractive for
crime case investigations in its current form. However, it may be
useful for relationship testing, especially when the costs of the
assay are taken into consideration. The list-price of the iPLEX1
Sample ID Plus Panel is 7 Euro/sample (including all reagents
and the SpectroCHIP1 MALDI-TOF MS target). This is one third
of the list-price of the widely used AmpFlSTR1 NGM SElectTM
(AB-LT) STR typing kit (not including the cost of the CE).
Furthermore, MALDI-TOF MS platforms require less mainte-
nance than the CE-platforms used in most forensic genetic
laboratories. For the same reasons, the iPLEX1 Sample ID Plus
Panel may be a fast and cost-effective method for sample
tracking of e.g. frequently used human cell lines, hospital or
biobank samples, etc., where the amount of sample material is
less of a concern.
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